Chronic necrotizing pulmonary aspergillosis: Pathologic outcome after itraconazole therapy

Mayo Clinic Proceedings

Volumn 71, Issue 1, 1996, Pages 25-30

  Caras, William E ^a   Pluss, Jerry L ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CISPLATIN; ETOPOSIDE; ITRACONAZOLE;

ADULT; AGED; ARTICLE; ASPERGILLUS; AUTOPSY; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIFE EXPECTANCY; LUNG ASPERGILLOSIS; LUNG SMALL CELL CANCER; MALE; ORAL DRUG ADMINISTRATION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0030031153     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/71.1.25     Document Type: Article

References (32)

1. Gefter WB, Weingrad TR, Epstein DM, Ochs RH, Miller WT. "Semi-invasive" pulmonary aspergillosis: a new look at the spectrum of Asperqillus infections of the lung. Radiology 1981; 140:313-321
2. Binder RE, Paling LJ, Pugatch RD, Mahasaen C, Snider GL. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine 1982; 61:109-124
3. Taylor KB, Thomas HL. Gastrointestinal and liver diseases. In: Stiles DP, Stopo JD, Wells JV, editors. Basic & Clinical Immunology. 6th ed. Norwalk(CT): Appleton & Lange, 1987: 474-475
4. Amman AJ. Immunodeficiency states. In: Stiles DP, Stopo JD, Wells JV, editors. Basic & Clinical Immunology. 6th ed. Norwalk (CT): Appleton & Lange, 1987: 317-355
5. Atkinson GW, Israel HL. 5-Fluorocytosine treatment of meningeal and pulmonary aspergillosis. Am J Med 1973; 55:496-514
6. Peer ET. Case of aspergillosis treated with amphotericin "B." Dis Chest 1960; 38:222-230
7. Hargis JL, Bone RC, Stewart J, Rector N, Miller FC. Intracavitary amphotericin B in the treatment of symptomatic pulmonary aspergillomas. Am J Med 1980; 68:389-394
8. Husebye KO. Serial studies in a case of pulmonary aspergillosis. Dis Chest 1967; 51:327-332
9. Foushee JHS, Norris FG. Pulmonary aspergillosis: a case report. J ThoracSurg 1958; 35:542-548
10. Macartney JN. Pulmonary aspergillosis: a review and a description of three new cases. Thorax 1964; 19:287-297
11. Dupont B, Drouhet E. Early experience with itraconazole in vitro and in patients: pharmacokinetic studies and clinical results. Rev Infect Dis 1987; 9(Suppl 1):S71-S76
12. Denning DW, Hanson LH, Perlman AM, Stevens DA. In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents. Diagn Microbiol Infect Dis 1992; 15:21-34
13. Dupont B. Itraconazole therapy in aspergillosis: study in 49 patients. J Am Acad Dermatol 1990; 23:607-614
14. De Beule K, De Doncker P, Cauwenbergh G, Koster M, Legendre R, Blatchford N, et al. The treatment of aspergillosis and aspergilloma with itraconazole: clinical results of an open international study (1982-1987). Mycoses 1988; 31:476-485
15. Kern ME. Laboratory procedures for fungal culture and isolation. In: Kern ME, editor. Medical Mycology. Philadelphia: FA Davis, 1991:41-67
16. Stiles DP, Rodgers RPC. Clinical laboratory methods for detection of antigens and antibodies. In: Stites DP, Stopo JD, Wells JV, editors. Basic & Clinical Immunology. 6th ed. Norwalk (CT): Appleton & Lange, 1987: 241-284
17. Hunt W III, Broders AC Jr, Stinson JC, Carabasi RJ. Primary pulmonary aspergillosis with invasion of the mediastinal contents and lymph nodes. Am Rev Respir Dis 1961; 83:886-890
18. Utz JP, German JL, Louria DB, Emmons CW, Bartter FC. Pulmonary aspergillosis with cavitation: iodide therapy associated with an unusual electrolyte disturbance. N Engl J Med 1959; 260:264-268
19. Jewkes J, Kay PH, Paneth M, Citron KM. Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment. Thorax 1983; 38:572-578
20. Glimp RA, Bayer AS. Pulmonary aspergilloma: diagnostic and therapeutic considerations. Arch Intern Med 1983; 143:303-308
21. Fräser RS. Pulmonary aspergillosis: pathologic and pathogenetic features. Pathol Annu 1993; 28:231-277
22. Fraser RG, Paré JAP, Paré PD, Fraser RS, Généreux GP. Diagnosis of Diseases of the Chest. Vol 2. 3rd ed. Philadelphia: Saunders, 1989: 991-993
23. Chandler FW, Watts JC. Fungal infections. In: Dail DH, Hammar SP, editors. Pulmonary Pathology. New York: Springer-Verlag, 1988: 189-257
24. Seabury JH, Samuels M. The pathogenetic spectrum of aspergillosis. Am J Clin Pathol 1963; 40:21 -33
25. Rafferty P, Biggs BA, Crompton GK, Grant IW. What happens to patients with pulmonary aspergilloma? Analysis of 23 cases. Thorax 1983; 38:579-583
26. Leggat PO, De Kretser DM. Aspergillus pneumonia in association with an aspergilloma. BrJ Dis Chest 1968; 62:147-150
27. Hammerman KJ, Sarosi GA, Tosh FE. Amphotericin B in the treatment of saprophytic forms of pulmonary aspergillosis. Am Rev Respir Dis 1974; 109:57-62
28. Conen PE, Walker GR, Turner JA, Field P. Invasive primary aspergillosis of the lung with cerebral metastasis and complete recovery. Dis Chest 1962; 42:88-94
29. Denning DW, Lee JY, Hosteller JS, Pappas P, Kauffman CA, Dewsnup DH, et al. NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis. Am J Med 1994;97:135-144
30. Viviani MA, Tortorano AM, Pagano A, Vigevani GM, Gubertini G, Cristina S, et al. European experience with itraconazole in systemic mycoses. J Am Acad Dermatol 1990; 23:587-593
31. Pluss JL, Opal SM. Pulmonary sporotrichosis: review of treatment and outcome. Medicine 1986; 65:143-153
32. Iseman MD, Madsen L, Goble M, Pomerantz M. Surgical intervention in the treatment of pulmonary disease caused by drug-resistant Mycobacterium tuberculosis. Am Rev Respir Dis 1990; 141:623625